- Cobimetinib - progress in the treatment of melanoma2017 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Research Report University Hospital for clinical assessment GO28141Publication without faculty affiliation
- Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial2018 | First Faculty of Medicine
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial2018 | First Faculty of Medicine
- Možnosti léčby metastazujícího melanomu v kazuistikách2017 | Publication without faculty affiliation
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- An open-label, multicentre safety study of vemurafenib in patients with BRAF(V600)-mutant metastatic melanoma: final analysis and a validated prognostic scoring system2019 | First Faculty of Medicine